GILD Gilead Sciences Inc

$108.22

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending 2025-06-30
Expected on Aug 05, 2025
Report Time: Unknown Release Time
The Whisper Number
$2.24
Consensus Estimate: $1.96
Revenue Estimate: $6.95B

Latest Earnings Insight

Updated On 7/18/2025

About Gilead Sciences Inc

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.

Website: https://www.gilead.com

Sector
LIFE SCIENCES
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
882095
Address
333 LAKESIDE DR, FOSTER CITY, CA, US
Valuation
Market Cap
$130.32B
P/E Ratio
275.11
PEG Ratio
0.22
Price to Book
6.74
Performance
EPS
$0.38
Dividend Yield
3.02%
Profit Margin
1.67%
ROE
2.29%
Technicals
50D MA
$108.53
200D MA
$90.76
52W High
$119.12
52W Low
$59.82
Fundamentals
Shares Outstanding
1B
Target Price
$112.74
Beta
0.34

GILD EPS Estimates vs Actual

● Estimated
● Actual

GILD News & Sentiment

Jul 18, 2025 • GlobeNewswire NEUTRAL
HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock
NEW YORK and VIENNA, July 18, 2025 ( GLOBE NEWSWIRE ) -- HOOKIPA Pharma Inc. ( NASDAQ: HOOK, "HOOKIPA" ) , a clinical-stage biopharmaceutical company developing next-generation immunotherapeutics for the treatment of cancer and serious infectious diseases, today announced its intention to ...
Jul 18, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Kymera Surges 70% in 3 Months: Buy, Sell or Hold the Stock?
KYMR jumps 70.7% in 3 months as the $750M oncology deal with GILD and pipeline advances in TPD drugs impress investors.
Jul 18, 2025 • Zacks Commentary SOMEWHAT-BULLISH
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Jul 17, 2025 • Benzinga SOMEWHAT-BULLISH
Aisera announces availability of Aisera Assistant in the new AWS Marketplace for AI Agents and Tools category
SANTA CLARA, Calif., July 17, 2025 ( GLOBE NEWSWIRE ) -- Aisera, a leading provider of agentic AI for business, today announced the availability of Aisera Assistant in the new AI Agents and Tools category of AWS Marketplace.
Jul 17, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Gilead Sciences, Inc. ( GILD ) is Attracting Investor Attention: Here is What You Should Know
Gilead (GILD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Jul 15, 2025 • Zacks Commentary NEUTRAL
Here's Why Gilead Sciences ( GILD ) Fell More Than Broader Market
Gilead Sciences (GILD) closed at $109.06 in the latest trading session, marking a -2.7% move from the prior day.
Sentiment Snapshot

Average Sentiment Score:

0.236
50 articles with scored sentiment

Overall Sentiment:

Bullish

GILD Reported Earnings

Feb 04, 2025
Dec 31, 2024 (Post market)
0.2 Surprise
  • Reported EPS: $1.90
  • Estimate: $1.70
  • Whisper: —
  • Surprise %: 11.7%
Nov 06, 2024
Sep 30, 2024 (Post market)
0.47 Surprise
  • Reported EPS: $2.02
  • Estimate: $1.55
  • Whisper: —
  • Surprise %: 30.3%
Aug 08, 2024
Jun 30, 2024 (Post market)
0.41 Surprise
  • Reported EPS: $2.01
  • Estimate: $1.60
  • Whisper: —
  • Surprise %: 25.6%
Apr 25, 2024
Mar 31, 2024 (Post market)
0.17 Surprise
  • Reported EPS: $-1.32
  • Estimate: $-1.49
  • Whisper: —
  • Surprise %: 11.4%
Feb 06, 2024
Dec 31, 2023 (Post market)
-0.04 Surprise
  • Reported EPS: $1.72
  • Estimate: $1.76
  • Whisper: —
  • Surprise %: -2.3%
Nov 07, 2023
Sep 30, 2023 (Post market)
0.37 Surprise
  • Reported EPS: $2.29
  • Estimate: $1.92
  • Whisper: —
  • Surprise %: 19.3%
Aug 03, 2023
Jun 30, 2023 (Post market)
0.02 Surprise
  • Reported EPS: $1.66
  • Estimate: $1.64
  • Whisper: —
  • Surprise %: 1.2%
Apr 27, 2023
Mar 31, 2023 (Post market)
-0.17 Surprise
  • Reported EPS: $1.37
  • Estimate: $1.54
  • Whisper: —
  • Surprise %: -11.0%
Feb 02, 2023
Dec 31, 2022 (Post market)
0.17 Surprise
  • Reported EPS: $1.67
  • Estimate: $1.50
  • Whisper: —
  • Surprise %: 11.3%

Financials